Literature DB >> 9676427

Parallel hybridization analysis of multiple protein kinase genes: identification of gene expression patterns characteristic of human hepatocellular carcinoma.

A P Tsou1, K M Wu, T Y Tsen, C W Chi, J H Chiu, W Y Lui, C P Hu, C Chang, C K Chou, S F Tsai.   

Abstract

Hepatocellular carcinoma (HCC) is one of the major causes of human cancer deaths worldwide. To identify alterations of the genetic program associated with human HCC, we designed a new protocol based on the high-density replica method to analyze protein kinase gene expression in normal liver, HCC, and HCC-derived cell lines. RNA was prepared for reverse transcription and cDNA was used for PCR amplification of the conserved catalytic domain of protein kinase genes. Initially, from a pair of HCC and the adjacent noncancerous tissues, we sequenced 228 samples and identified 26 genes that represent different tyrosine kinase subfamilies. High-density grid filters were then prepared to assist the identification, by hybridization, of genes that are differentially expressed in normal vs HCC samples. Eleven tyrosine kinase genes were tested, and positive signals were reliably scored by doubly offset duplicates and by two independent gene-specific probes. Of the 11 genes tested, PDGF receptor-beta, MEKK-3, axl, and FGFR-4 are preferentially expressed in tumor samples. Additionally, we analyzed protein kinase gene expression in five HCC cell lines and identified distinct kinase gene expression patterns in different cell lines. Our results suggest that multiple kinases are activated in different tumors and confirm that there is molecular heterogeneity in the mechanisms sustaining autonomous cell growth in liver tumor formation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9676427     DOI: 10.1006/geno.1998.5338

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  24 in total

Review 1.  Critical signal transduction pathways in CLL.

Authors:  Asish K Ghosh; Neil E Kay
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

2.  Axl receptor tyrosine kinase expression in breast cancer.

Authors:  Timothy M D'Alfonso; Jeffrey Hannah; Zhengming Chen; Yifang Liu; Pengbo Zhou; Sandra J Shin
Journal:  J Clin Pathol       Date:  2014-06-05       Impact factor: 3.411

3.  Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway.

Authors:  K O'Donnell; I C Harkes; L Dougherty; I P Wicks
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

Review 4.  Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors.

Authors:  Rachel M A Linger; Amy K Keating; H Shelton Earp; Douglas K Graham
Journal:  Expert Opin Ther Targets       Date:  2010-10       Impact factor: 6.902

Review 5.  TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.

Authors:  Rachel M A Linger; Amy K Keating; H Shelton Earp; Douglas K Graham
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

6.  Axl-targeted cancer imaging with humanized antibody h173.

Authors:  Dan Li; Shuanglong Liu; Ren Liu; Ryan Park; Haiyang Yu; Valery Krasnoperov; Parkash S Gill; Zibo Li; Hong Shan; Peter S Conti
Journal:  Mol Imaging Biol       Date:  2014-08       Impact factor: 3.488

7.  Hematopoietic progenitor kinase 1 down-regulates the oncogenic receptor tyrosine kinase AXL in pancreatic cancer.

Authors:  Xianzhou Song; Hironari Akasaka; Hua Wang; Reza Abbasgholizadeh; Ji-Hyun Shin; Fenglin Zang; Jiayi Chen; Craig D Logsdon; Anirban Maitra; Andrew J Bean; Huamin Wang
Journal:  J Biol Chem       Date:  2020-01-20       Impact factor: 5.157

8.  AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma.

Authors:  M Z Xu; S W Chan; A M Liu; K F Wong; S T Fan; J Chen; R T Poon; L Zender; S W Lowe; W Hong; J M Luk
Journal:  Oncogene       Date:  2010-11-15       Impact factor: 9.867

9.  Axl activates autocrine transforming growth factor-β signaling in hepatocellular carcinoma.

Authors:  Patrick Reichl; Mirko Dengler; Franziska van Zijl; Heidemarie Huber; Gerhard Führlinger; Christian Reichel; Wolfgang Sieghart; Markus Peck-Radosavljevic; Markus Grubinger; Wolfgang Mikulits
Journal:  Hepatology       Date:  2015-01-28       Impact factor: 17.425

10.  Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma.

Authors:  Patrick Reichl; Meng Fang; Patrick Starlinger; Katharina Staufer; Rudolf Nenutil; Petr Muller; Kristina Greplova; Dalibor Valik; Steven Dooley; Christine Brostjan; Thomas Gruenberger; Jiayun Shen; Kwan Man; Michael Trauner; Jun Yu; Chun Fang Gao; Wolfgang Mikulits
Journal:  Int J Cancer       Date:  2015-01-13       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.